ArticleMedicine2026
A machine learning model incorporating the globulin-to-platelet index for predicting severe fibrosis in autoimmune hepatitis: A retrospective and prospective validation study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate staging of liver fibrosis in autoimmune hepatitis (AIH) remains challenging due to the invasive nature and sampling limitations of liver biopsy. This study aimed to identify readily available predictors of severe fibrosis and to develop an AIH-specific noninvasive machine-learning model. This two-stage study retrospectively enrolled 208 patients with biopsy-confirmed AIH, with prospective validation in 26 additional patients. Transient elastography (TE) was performed in 110 retrospective and 12 prospective patients. Severe fibrosis was defined as Scheuer stages S3 to S4. Candidate variables underwent univariable and multivariable logistic regression with collinearity control. A random forest (RF) model was trained on the independent predictors and evaluated by the area under the receiver operating characteristic curve (AUROC), calibration, and decision curve analysis. Shapley Additive exPlanations were used for interpretability. Inflammatory activity was graded by Scheuer and prespecified for subgroup analyses (G0-G2 vs G3-G4). A TE-inclusive RF model was also developed in the TE subgroup. The globulin-to-platelet index, international normalized ratio, and blood urea nitrogen were identified as independent predictors of severe fibrosis in AIH. The RF model based on these variables yielded AUROCs of 0.863 (95% confidence interval [CI], 0.802-0.917) in the training set, 0.747 (95% CI, 0.602-0.863) in the test set, and 0.784 (95% CI, 0.556-0.959) in the prospective cohort. Stratified by inflammatory grade, AUROCs were 0.842 (95% CI, 0.757-0.914) in G0-G2 and 0.814 (95% CI, 0.726-0.886) in G3-G4. In contrast, the aspartate aminotransferase-to-platelet ratio index and fibrosis-4 index performed poorly overall and deteriorated further under moderate-to-severe inflammation. In the TE subgroup, the RF model outperformed TE alone (AUROC, 0.786 vs 0.682), and performance improved further when TE was integrated (AUROC, 0.898 [95% CI, 0.841-0.949]). Globulin-to-platelet index, international normalized ratio, and blood urea nitrogen were independent predictors of severe fibrosis in AIH. An RF model constructed from these markers provided a robust, noninvasive tool whose performance was preserved across inflammatory grades and was further enhanced by incorporating TE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.